Original Article

You have full text access to this OnlineOpen article

Impact of alcohol on the histological and clinical progression of Hepatitis C infection

  1. Thelma E. Wiley M.D. Assistant Professor of Medicine*,
  2. Mary McCarthy,
  3. Lama Breidi,
  4. Monica McCarthy,
  5. Thomas J. Layden

Article first published online: 30 DEC 2003

DOI: 10.1002/hep.510280330

Issue

Hepatology

Hepatology

Volume 28, Issue 3, pages 805–809, September 1998

Additional Information

How to Cite

Wiley, T. E., McCarthy, M., Breidi, L., McCarthy, M. and Layden, T. J. (1998), Impact of alcohol on the histological and clinical progression of Hepatitis C infection. Hepatology, 28: 805–809. doi: 10.1002/hep.510280330

Author Information

  1. Section of Digestive and Liver Diseases, University of Illinois at Chicago Medical Center, Chicago, IL

*Section of Digestive and Liver Diseases, University of Illinois at Chicago, 840 S. Wood Street m/c 787, Chicago, IL 60612-7323. Fax: (312) 996-5103

Publication History

  1. Issue published online: 30 DEC 2003
  2. Article first published online: 30 DEC 2003
  3. Manuscript Accepted: 2 APR 1998
  4. Manuscript Received: 30 SEP 1997

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (75K)

References

  • 1
    Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332:1463–1466.MEDLINE
  • 2
    Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpoler JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991; 14:969–974.MEDLINE
    Direct Link:
  • 3
    Takahashi M, Yamada G, Miyamato R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Gastroenterol 1993; 88:240–243.MEDLINE
  • 4
    Seeff LB, Buskell-Bales Z, Wright EC, Durato SJ, Alter HJ, Iber FL, et al. Long term mortality after transfusion-associated nonA, nonB hepatitis. N Engl J Med 1992; 27:1906–1911.
  • 5
    Tassopoulos NC. Patterns of progression: Unpredictability and risk of decompensated cirrhosis 12. Dig Dis Sci 1996; 41:41S–48S.MEDLINE
  • 6
    Befrits R, Hedman M, Blomquist L, Allander T, Grillner L, Kinnman N, Rubio C, et al. Chronic hepatitis C in alcoholic patients: Prevalence, genotypes and correlation to liver disease. Scand J Gastroenterol 1995; 30:1113–1118.MEDLINE
  • 7
    Coelho-Little ME, Jeffers LJ, Bernstein DE, Goodman JJ, Reddy KR, de Medina M, Li X, et al. Hepatitis C virus in alcoholic patients with and without clinically apparent liver disease 5. Alcohol Clin Exp Res 1995; 19:1173–1176.MEDLINE
    Direct Link:
  • 8
    Caldwell SH, Li S, Rourk RM, Millar A, Sosnowski KM, Sue M, Barritt AS, et al. Hepatitis C infection by polymerase chain reaction in alcoholics: False-positive ELISA results and the influence of infection on a clinical prognostic score 7. Am J Gastroenterol 1993; 88:1016–1021.MEDLINE
  • 9
    Mendenhall CL, Seeff L, Diehl AM, Ghosn SJ, French SW, Gartside PS, Rouster SD, et al. Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: Their prevalence and clinical relevance. Hepatology 1991; 14:581–589.MEDLINE
    Direct Link:
  • 10
    Caldwell SH, Jeffers LJ, Ditomease A, Millar A, Clark RM, Rabassa A, Reddy KR, et al. Antibody to hepatitis C is common among patients with alcoholic liver disease with and without risk factors. Am J Gastroenterol 1991; 86:1219–1223.MEDLINE
  • 11
    Pares A, Barrera JM, Caballeria J, Ercilla G, Bruguera M, Caballeria L, Castillo R, et al. Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. Hepatology 1990; 12:1295–1299.MEDLINE
    Direct Link:
  • 12
    Nishiguchi S, Kuroki R, Yabusako T, Seki S, Kobayashi K, Monna T, Otani S, et al. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. Hepatology 1991; 14:985–989.MEDLINE
    Direct Link:
  • 13
    Bellentani S, Tiribelli C, Saccoccio G, Soddle M, Frutti N, DeMartin C, Christianni G, et al. Prevalence of chronic liver disease in the general population of Northern Italy. The Dionysos Study. Hepatology 1994; 20:1442–1449.MEDLINE
    Direct Link:
  • 14
    Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahome Y, Sugai Y, Tanaka T, et al. Typing hepatitis C virus by polymerase chain reaction with type specific primers application to clinical surveys and tracing infection sources 3. J Gen Virol 1992; 73:673–679.MEDLINE
  • 15
    Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1:431–439.MEDLINE
    Direct Link:
  • 16
    Alter HJ. To C or not to C: these are the questions. Blood 1995; 85:1681–1695.MEDLINE
  • 17
    Pistello M, Maggi F, Vatteroni L, Ceccini N, Panicucci F, Bresci GP, Gambardella L, et al. Prevalence of hepatitis C virus genotypes in Italy. J Clin Microbiol 1994; 32:232–234.MEDLINE
  • 18
    Pozzato G, Moretti M, Crocé LS, Sasso F, Kaneko S, Unoura M, Kobayashi M, et al. Interferon therapy in chronic hepatitis C virus: evidence of different outcome with respect to viral strains. J Med Virol 1995; 45:445–450.MEDLINE
    Direct Link:
  • 19
    Silini E, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, Belloni G, et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 1995; 21:285–290.MEDLINE
  • 20
    Nousbaum J-B, Pol S, Nalpas B, Landais P, Berthelot P, Bréchot C. Hepatitis C virus types 1b (II) infection in France and Italy. the Collaborative Study Group. Ann Intern Med 1995; 122:161–168.MEDLINE
  • 21
    Mita E, Hiyashi N, Kanazawa Y, Hagiwara H, Ueda K, Kasahara A, Fusumato H, et al. Hepatitis C virus genotype and RNA titers in the progression of type C chronic liver disease. J Hepatol 1994; 21:468–473.MEDLINE
  • 22
    Yamada M, Kakumu S, Yoshioka K, Higashi Y, Tanaka K, Ishikawa T, Takayanegi M. Hepatitis C virus genotypes are not responsible for development of serious liver disease. Dig Dis Sci 1994; 39:234–239.MEDLINE
  • 23
    Oshita M, Hayashi N, Kasahara A, Hagiwara H, Mita E, Naito M, Katayama K, et al. Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C. Hepatology 1994; 20:1115–1120.MEDLINE
    Direct Link:
  • 24
    Takase S, Matsuda Y, Sawada M, Takada N, Takada A. Effect of alcohol abuse on HCV replication. Gastroenterologia Japonica 1993; 28:322.MEDLINE
  • 25
    Anand BS, Valez M. Does alcohol abuse influence hepatitis C virus replication. Gastroenterology 1997; 112:A1211.
  • 26
    Strasser SI, Watson KRJ, Lee CS, Coghlan PJ, Desmond PV. Risk factors and prediction of outcome in an Australian cohort with hepatitis C infection. Med J Aust 1991; 162:355–358.
  • 27
    Kao JH, Tsai SL, Chen PJ, Yang PM, Shev JC, Lai MY, Hsu HC, et al. A clinicopathological study of chronic nonA, nonB hepatitis in Taiwan: comparison between post-transfusion and sporadic patterns. Hepatology 1994; 21:244–249.
  • 28
    Gordon SC, Ellaway RS, Long JC, Dmuchowski CF. Pathology of hepatitis C as function of mode of transmission: blood transfusion vs. intravenous drugs. Hepatology 1993; 18:1338–1343.MEDLINE
    Direct Link:
  • 29
    Roudot-Thoraval F, Bastie A, Pawlotsky JM, Dhumeaux D. Epidemiologic factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C. Hepatology 1997; 26:485–490.MEDLINE
    Direct Link:
  • 30
    VanThiel DH, Friedlander L, Fagiuoli S, Wright HI, Irish W, Gavaler JS. Response to interferon-α therapy is influenced by the iron content of the liver. J Hepatol 1994; 20:410–415.MEDLINE
Get PDF (75K)